Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Jennifer K. Simpson
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
therapies for cancer
|
| gptkbp:focusesOn |
oncology
pancreatic cancer gastrointestinal cancers |
| gptkbp:formerName |
Sun BioPharma, Inc.
|
| gptkbp:foundedYear |
2011
|
| gptkbp:headquartersLocation |
gptkb:Minneapolis,_Minnesota,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Panbela Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
Flynpovi
SBP-101 |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:PBLA
|
| gptkbp:website |
https://panbela.com/
|
| gptkbp:bfsParent |
gptkb:SPB101
|
| gptkbp:bfsLayer |
8
|